MUSTANG BIO, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-06-30 was 0.00 shares.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-03-31 was 2.66K shares, a 97.93% decline year-over-year.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-12-31 was -125.79K shares.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 2.76K shares, a 7.81% increase from fiscal 2024.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 2.56K shares, a 97.04% decline from fiscal 2023.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 86.58K shares, a 85.23% decline from fiscal 2022.
- MUSTANG BIO, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 586.01K shares, a 129.65% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 2.76K shares 10-K · filed 2026-03-19 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -123.13K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 2.66K shares 10-Q · filed 2025-05-14 | -123.13K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | -125.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 2.56K shares 10-K · filed 2025-03-28 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 128.35K shares derived: sum of 4 quarters · filed 2024-11-08 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 163.22K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 128.35K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 86.58K shares 10-K · filed 2024-03-11 |
| 2023-09-30 | 34.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 586.01K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 173.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 726.87K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 611.67K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 412.46K shares 10-Q · filed 2022-05-12 | 611.67K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 140.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 255.18K shares 10-K · filed 2022-03-23 |
| 2021-09-30 | 58.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 114.32K shares derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 128.47K shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 55.96K shares 10-Q · filed 2021-05-14 | 196.82K shares derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 140.86K shares 10-K · filed 2021-03-24 |
| 2020-09-30 | 72.50K shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 68.35K shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 68.35K shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |